Laura Terrell’s Post

Discover Leaders League new rankings for Switzerland Best Law Firms for Life Sciences: IP and Life Sciences: Regulatory, available now at the links below: Switzerland Best Law Firms for Life Sciences: IP - https://lnkd.in/gi4WPChq Switzerland Best Law Firms for Life Sciences: Regulatory - https://lnkd.in/gpg-TsSf Among ranked firms for Life Sciences: IP this year were: MLL Legal, Pestalozzi Attorneys at Law, TIMES Attorneys, Bratschi Ltd., CMS Switzerland, Niederer Kraft Frey, among others. Some of the #LawFirms ranked this year for Life Sciences: Regulatory are: Bär & Karrer, Kellerhals Carrard, Lenz & Staehelin, VISCHER, Homburger, Wenger Plattner, Wenger Vieli, and more. #ranking #lifesciences #regulatorylaw #avocats #legal

#Synthesis: #USPTO’s guidance provides insights into #GenAI in #DrugDiscovery; #RegenxBio departs from previous case law. #PatentEligibility #NucleicAcid #Inventorship #LifeSciences #IntellectualProperty

Why do Daubert decisions matter so much in Mass Torts? In all litigations the Plaintiff has the burden to prove their case. In complex Mass Torts with scientific information, this involves a number of experts. In order to have expert admitted in federal court to be allowed to present their opinions to the jury, the expert's opinion must meet certain requirements. The Daubert Standard, established in 1993 in Daubert v. Merrell Dow Pharmaceuticals, provides the framework where a trial court judge evaluates the reliability and relevance of expert testimony before it is allowed to be presented to the jury. In essence, the judge serves as a "gatekeeper" of the scientific evidence to see what can and what can't be shown to the jury. The idea is to prevent "junk science" from being presented to the juror that could improperly sway their decision. Sometimes a Mass Tort judge rules quickly on Daubert motions like we saw in the Zantac MDL and sometimes the judge take longer like we see in Paraquat. In a Mass Tort, if Plaintiffs are able to satisfy their burden and get experts admitted under Daubert, this is a monumental decision and strongly swings the litigation in favor of Plaintiffs. It is much less risky to get involved post-Daubert as you know the cases will be able to proceed to the jury. The Mass Tort world is awaiting decisions Daubert decisions in Tylenol and Paraquat that will determine the faith of those litigations. #joedoeslaw #masstorts #daubert

Rothwell Figg partner Aydin H. Harston is recommended for Patent Prosecution in the D.C. Metro Area by the IAM Patent 1000, a ranking shining a spotlight on firms and individuals deemed outstanding in the area of patent law. Aydin, who holds a Ph.D. in biochemistry, integrates scientific expertise with legal experience to help his clients grow, protect, and defend the intellectual property that powers their businesses. Learn more about Aydin: https://lnkd.in/e49rQAf7 #patentprosecution #patentlaw #IAMPatent10002024 #patentattorney

Excited to share the latest issue of The Interplay from WilmerHale. Read recent updates at the intersection of Antitrust & Life Sciences. Stay informed on the latest industry insights! #Antitrust #LifeSciences

General counsels in the life sciences industry face a multitude of complexities in support of growth and innovation, particularly in connection with the increasing prevalence of artificial intelligence, end of Chevron deference, and the upcoming presidential election. My colleague Jourdan Garvey, as Secretary/Treasurer of the Business Law Section of the Philadelphia Bar Association, is honored to coordinate one of the Section’s major events of the year, “Spotlight on In-House Counsel,” being held Tuesday, October 1, at the Pyramid Club in Philadelphia, PA. Adam Yoffie (Bristol Myers Squibb) will moderate a panel including in-house counsels Neena Patil (Jazz Pharmaceuticals), James A. Petkun (The START Center for Cancer Research), and H.W. Jerome Maddox (Fox Chase Cancer Center) in a discussion about these challenges facing them as legal advisors to their clients in the midst of evolving technological and societal issues that are forcing organizations to modernize operations and confront new legal and ethical questions. Learn more: bit.ly/4epRrrW #lifesciencesindustry #inhousecounsel #generalcounsel #businesslaw

Meet some of the powerhouse women IP lawyers in Crowell’s Biotech Practice. Bloomberg Law spoke with Terry Rea as she departs Crowell to start a consultancy after a four-decade IP law career, and the group of female attorneys she has mentored who are now leading the way in the traditionally male-dominated field of patent law. Read the story here. #IP #Biotech #LifeSciences #PTAB #Women

Just launched! Legal 500 and Legal Business Magazine present the Life Sciences Yearbook 2024 in association with Herbert Smith Freehills. Marie Johansen Nordland talks to leading London lawyers about patent trends in the life sciences sector, while Sophie Chan looks at recent regulatory reforms and assesses the UK’s position in a post-Brexit, post-Covid world. We also have interviews with Covington & Burling LLP's Grant Castle, and with rising stars of the sector Zina Chatzidimitriadou and Dr Chris Boyle of Sidley Austin LLP, Baker McKenzie’s Jaspreet Takhar and McDermott Will & Emery's David Gibson. With contributions from our lead partner Herbert Smith Freehills on whether 2024 is the year the United Kingdom becomes a globally leading life sciences hub, there are also country focuses from Fangda Partners and Sérvulo & Associados. View the complete publication online now at: https://lnkd.in/e2Q7zfi6 We hope you enjoy it - if you'd like to get involved in future editions, please do get in touch with Georgina Stanley or John Jennings. #legal500 #legalbusiness #lifesciences #lifesciencesyearbook

A review of 2023 and what to expect in 2024….

See the latest client ratings and testimonial for Partner, XU Tao of Lianggao Law Firm. Yingnan ZHAO, General Counsel of Gritgen commented, "The expertise of Mr. Xu lies in the laws and practices governing overseas investment, enabling him to effectively assist clients in resolving intricate issues." Zhiling JI, Senior Director of WuXi Biologics also added, "Lawyer Xu is richly experienced in handling complex domestic and cross-border private equity and M&A transactions, we are highly appreciated for his expertise and quick turn-around." LegalOne Client Rating and testimonial can be found on the lawyer's profile page:  https://lnkd.in/gQc_faCw For more information, please visit our website at www.legaloneglobal.com or contact us at enquiry@legaloneglobal.com. #LegalOne #Legaloneclientrating #legal #lawyer #lawyers #lawfirm #lawfirms #GeneralCounsel #inhousecounsel #legalprofession #corporateexecutive #China